pharmaceutical policies Archives

How Global Pharmacy Practices Compare to the U.S. System

Brian RogersJune 6, 20240188 views

This article compares the accessibility of antibiotics, erectile dysfunction medications, and acne treatments across various countries, highlighting the differences between prescription requirements and over-the-counter (OTC) availability. While the U.S. enforces strict prescription regulations, leading to higher costs and lower customer satisfaction, many other countries offer broader OTC access, resulting in greater satisfaction and lower costs. The analysis underscores the need for the U.S. to adopt a balanced approach that maintains safety while improving access to medications.

The FDA’s Hypocrisy: Blocking Access to WHO-Approved Pharmaceuticals While Allowing Unregulated Research Chemicals

Brian RogersMay 31, 20240126 views

The FDA, tasked with protecting public health, faces criticism for its double standards in regulatory enforcement. While it blocks WHO-approved pharmaceuticals from India, limiting access to affordable medications, it allows the unregulated proliferation of research chemicals like SARMs within the U.S. This selective enforcement extends to dietary supplements and food additives, posing significant risks to consumers. This article calls for accountability and meaningful reform to ensure the FDA prioritizes public health over corporate interests.

The Erosion of Health Autonomy: The Struggle for Pharmaceutical Freedom in America

Brian RogersMay 29, 20240150 views

The FDA, while crucial for public health, also limits access to affordable medications through its lengthy and costly drug approval process. This affects the availability of cheaper generics and restricts personal importation of prescription drugs. In contrast, countries like the UK and Canada regulate drug prices to ensure affordability. The current U.S. policies leave many Americans cutting pills, skipping doses, or forgoing medications due to high costs. Advocacy for change is essential to promote transparency in drug pricing, reform the FDA’s approval process, and allow safe importation of prescription drugs, ensuring health autonomy for all Americans.